the first clinical studies indicate that two additional therapeutic targets , which are not reached with classical neuroleptics , may be obtained with risperidone in the monotherapy of schizophrenia and related disorders : very important contact and mood-elevating properties and extrapyramidal symptoms-free maintenance therapy .
C0073393
risperidone
C0036341
schizophrenia